(Sample) Ebola Research Begins at NEIDL

(Sample Post) Eight months after receiving final approval from the Boston Public Health Commission to conduct research at Biosafety Level 4 (BSL-4), Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) has begun work with its first Level-4 pathogen, the Ebola virus. “This is clearly an important step for the NEIDL,” says Ronald B. Corley, NEIDL director and a […]


(Sample) BU-Based CARB-X Antimicrobial Partnership Gets Another $50 Million Plus

(Sample Post) In a sign of the growing recognition of the threat of antibiotic resistance, the Bill & Melinda Gates Foundation and the UK government are joining CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator), a BU-based public-private partnership launched two years ago by the US Department of Health and Human Services (HHS) to give financial, […]

Tagged: ,

(Sample) BU Wins $20M for NSF Engineering Research Center

(Sample Post) FOR IMMEDIATE RELEASE: September 14, 2017 CONTACT: Rachel Lapal, rlapal@bu.edu Boston University has won a $20 million, five-year award from the National Science Foundation (NSF) to create a multi-institution Engineering Research Center (ERC), with the goal of synthesizing personalized heart tissue for clinical use. The grant, which is renewable for a total of […]